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Summary
BACKGROUND: The role of income in cardiovascular dis-
ease prevention after an acute coronary syndrome (ACS)
remains unclear. We aimed to assess the association be-
tween income and control of cardiovascular risk factors
one year after an ACS in a country with universal health
insurance.
METHODS: Between 2013 and 2014, we studied 255 con-
secutive patients with ACS in an observational study in
a university hospital in Switzerland in which self-report-
ed household income was assessed. We classified pa-
tients into two categories based on the median income in
Switzerland: higher than CHF 6000 (€ 5300) or less than
or equal to CHF 6000 (€ 5300) per month. One year after
discharge, patients were evaluated for the achievement of
lipid and blood pressure targets, smoking cessation and
drug adherence. Multivariate odds ratios (OR) were ad-
justed for age, sex, education, living status and working
status.
RESULTS: Overall, 52.2% (n = 133) of patients with ACS
were in the low-income category and 47.8% (n = 122)
were in the high-income category. One year after dis-
charge, high-income patients had higher rates of smoking
cessation (64.2 vs 30.1%, multivariate-adjusted odds ratio
(OR) 3.82, 95% confidence interval (CI) 1.58–9.24) and
blood pressure target achievement (78.6 vs 60.2%, mul-
tivariate-adjusted OR 2.19, 95% CI 1.09–4.41) compared
to those in the low-income category. There were no dif-
ferences regarding adherence to drugs or lipid control be-
tween the two income groups.
CONCLUSION: A high household income was associated
with a higher rate of smoking cessation and better control
of blood pressure one year after ACS, independently of
education, living status and working status.
Keywords: income, acute coronary syndrome, hyperten-
sion, dyslipidaemia, smoking cessation
Introduction
Socioeconomic status is a major determinant of a healthy
life. In Europe and worldwide, socioeconomic status has
been associated with cardiovascular events and mortality
in many observational studies [1–10]. However, the mech-
anisms underlining these associations are debatable be-
cause socioeconomic status encompasses many compo-
nents, including education and professional, familial and
cultural status. In particular, few studies have focused on
the relationship between income and cardiovascular dis-
ease, maybe because many industrialised countries, includ-
ing Switzerland, have implemented universal health in-
surance. The concept of universal health insurance is to
extend access to health care as widely as possible, limiting
the impact of individual wealth.
Switzerland is a rich country, with a median salary of CHF
6189 (€ 5683) in 2014 according to the Federal Statistical
Office [11]. Moreover, universal health insurance coverage
is compulsory in Switzerland in order to protect the popu-
lation against the renunciation of private health care. In this
context, we aim to assess the association between income
and control of cardiovascular risk factors one year after an
acute coronary syndrome (ACS).
Methods
Study population
Between 28 January 2013 and 12 August 2014, we recruit-
ed 277 patients hospitalised with ACS in a university hos-
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pital in Switzerland as part of the SPUM-ACS cohort [12].
The inclusion criteria were a main diagnosis of ACS with
increased troponins, modifications of electrocardiography
and the presence of atherosclerosis in angiography. An ex-
clusion criterion was the refusal to participate in the one-
year follow-up visit.
Household income assessment
Self-reported household income was defined as the income
of all the people living under the same roof and after the
deduction of compulsory social insurance contributions,
pension funds and child allowances. In the questionnaire,
patients could choose to state their annual income in two
different ways. They could directly state their net house-
hold income, or they could select from predefined income
categories: less than CHF 3000 (€ 2560); less than CHF
4500 (€ 3413.30); more than CHF 4500 (€ 3413.30); less
than CHF 6000 (€ 5120); less than CHF 6000 (€ 5120);
less than CHF 9000 (€ 7680); less than CHF 9000 (€
7680) (table S1 in appendix 1). We excluded 22 patients
for whom income information was missing. The final sam-
ple was 255 patients. We then classified patients into two
income categories: high-income (higher than CHF 6000
(€ 5120) per month) and low-income (less than or equal
to CHF 6000 (€ 5120) per month), based on the median
monthly income in Switzerland of CHF 6189 (€ 5683)
[11].
Covariables
Demographic and socioeconomic status were assessed
with a validated self-reported questionnaire at baseline
and/or at one year. Education was categorised into high-
school level or higher, or less than high-school. Marital
status was classified as married or not. Living status was
classified as living alone or with someone. Working status
comprised full time, part time and unemployed. Smoking
status was categorised into never, former and current
smoker. Health insurance deductibles was categorised in
two groups: low, defined as CHF 300 or 500 (€ 256 or €
426.60), and high, defined as CHF 1000, 1500, 2000 or
2500 (€ 853.30, € 1280, € 1706.60 or € 2133.30). Hyper-
tension was defined as systolic blood pressure >140 mm
Hg and diastolic >90 mm Hg or use of antihypertensive
drugs. Physical activity was measured with the Interna-
tional Physical Activity Questionnaire (IPAQ). We used
a validated self-assessed questionnaire, the 20-items Cen-
ter for Epidemiologic Studies Depression Scale (CES-D),
to screen for depression (score ≥16) during hospitalisation
[13]. The cut-off values used to stratify the variables were
based on standards used for cardiovascular disease preven-
tion in clinics [14].
Outcomes
One year after hospital discharge, control of cardiovascular
risk factors was assessed during a face-to-face clinical visit
with a study nurse. Lipid profile was measured and
processed locally using standardised and certified dosage
methods. LDL cholesterol was calculated using the Friede-
wald formula when triglyceride levels were below 4.5
mmol/l. Targets for cardiovascular risk factors one year af-
ter discharge included:
1. Optimal lipid target, defined as LDL cholesterol below
1.8 mmol/l or a 50% decrease from baseline, or the use
of high-dose statin (atorvastatin 40 mg or rosuvastatin
20 mg).
2. Optimal blood pressure target, defined as blood pres-
sure below 140 mm Hg for systolic and below 90 mm
Hg for diastolic blood pressure.
3. Smoking cessation for current smokers at baseline.
Smokers with missing information at one year were
considered as continuous smokers. A sensitivity analy-
sis considering smokers with missing information
about one-year smoking cessation as non-smokers is
reported in table S2 (appendix 1).
4. Optimal drug adherence according to guidelines, de-
fined as the concomitant use of aspirin, statin and ei-
ther angiotensin-converting enzyme inhibitors, an-
giotensin-receptor blockers or beta-blockers.
Statistical analysis
Baseline characteristics are presented as means ± standard
deviations or frequencies and percentages. To assess the
association between income and control of cardiovascular
risk factors one year after hospitalisation, we used unad-
justed and multivariate adjusted logistic regression models
for each outcome and reported odds ratios (ORs) with 95%
confidence intervals (95% CIs). In model I, crude analysis
was performed. In model II, we adjusted for age and sex,
and in model III we further adjusted for education, living
status and working status to take into account major so-
cio-demographic variables. The variables included in the
multivariate-adjusted model were not determined accord-
ing to statistical significance, but based on their potential
socioeconomic impact. To avoid overadjustment, marital
status was not included in the model, because married pa-
tients had a higher household income that patients who
lived alone. Due to the observational nature of the study,
no formal sample size calculation was performed, but all
available patients with information on income were includ-
ed. All hypothesis tests were two-sided, and the signifi-
cance level was set at 5%. Statistical analyses were per-
formed using STATA 14® (STATA Corp, College Station,
TX, USA).
Medical Ethics Committee
The Medical Ethics Committee of Lausanne approved the
study and all participants gave written informed consent to
participation in the study.
Results
Overall, 52.2% (n = 133) of patients with ACS were in
the low-income category, and 47.8% (n = 122) in the high-
income category. A monthly household income of below
CHF 3000 (€ 2560) was reported by 29(11.4%) of patients.
This is close to the threshold of poverty in Switzerland, de-
fined as below CHF 2500 (€ 2133.30). The baseline char-
acteristics of the study population by income category are
reported in table 1. Patients in the low-income category
were older and more frequently men than those in the high-
income category. Patients in the low-income category al-
so had a lower level of education, more frequently lived
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alone, and worked full-time less frequently compared to
patients in the high-income category.
One-year rates of ideal cholesterol management did not
differ significantly between the two income categories, al-
though there was a trend, with 82% achieving ideal cho-
lesterol management for the high and 69.8% for the low-
income category (age- and sex-adjusted OR 1.6, 95% CI
0.84–3.03, p = 0.15) (table 2 and fig. 1). In contrast, more
patients in the high-income category reached blood pres-
sure targets than in the low-income category (78.2% vs
60.2%, age- and sex-adjusted OR 2.37, 95%CI 1.25–4.52,
p = 0.008). This association was slightly modified after
further adjustment for education, living status and working
status (multivariate-adjusted OR 2.19, 95% CI 1.09–4.41,
p = 0.029). One year after hospital discharge, more base-
line smokers in the high-income category had stopped
smoking than in the low-income category (64.2% vs
30.1%, age- and sex-adjusted OR 4.74, 95% CI
2.13–10.59, p <0.001; multivariate-adjusted OR 3.82, 95%
CI 1.58–9.24, p = 0.003). There were no differences in the
rates of treatment adherence between the two income cat-
egories, with 88% for the high- and 84.9% for the low-
income category (age- and sex-adjusted OR 1.08, 95%
CI 0.49–2.38, p = 0.86; multivariate-adjusted OR 1.27,
95%CI 0.55–2.94, p = 0.58).
Visits to a primary care physician one year after acute coro-
nary syndrome did not differ significantly between the two
income categories, with 98.3% for the high- and 97.6% for
the low-income category (p = 0.71) (table 3). In contrast,
more patients in the high-income category visited a cardi-
ologist than in the low-income category (96.6 vs 82.9%,
p = 0.001). One year after hospital discharge, there was
no significant difference for cardiac rehabilitation between
the two income categories, with 79.8% for the high- and
72.6% for the low-income category (p = 0.19). There was
no difference in use of hypertensive drugs between the two
income categories, with 97.6% for the low- and 94% for
the high-income category (p = 0.16).
Discussion
Among patients with ACS from a university hospital living
in the French-speaking part of Switzerland, with universal
health insurance coverage, we found that long-term control
of cardiovascular risk factors was worse among patients
with an income below the Swiss median compared to those
Table 1: Baseline characteristics by household income status (n = 255).
Low income*
(n = 133)
High income†
(n = 122)
p-value
Demographics Age, years 64.2 (13) 59.8 (10.4) 0.004
Men, no. (%) 91 (68.4) 111 (91) <0.001
Caucasian, no. (%) 131 (98.5) 120 (98.4) 0.51
Education
(n = 253)
High school or higher, no. (%) 29 (22.1) 56 (45.9) <0.001
Marital status Married, no. (%) 57 (42.9) 88 (72.1) <0.001
Living status
(n = 229)
Alone, no. (%) 53 (39.9) 18 (14.9) <0.001
Working status
(n = 253)
Full time, no. (%) 41 (30.8) 62 (51.7) 0.003
Part time, no. (%) 16 (12) 11 (9.2)
Unemployed, no. (%) 76 (57.1) 47 (39.2)
Health insurance Monthly premium, CHF (n = 253) 425 (149) 416 (129) 0.63
Low deductible‡, no. (%) (n = 247) 102 (80.9) 78 (64.5) 0.004
Supplemental private, no. (%) (n = 154) 45 (54.2) 52 (73.2) 0.015
Smoking status Never, no. (%) 41 (30.8) 44 (36.1) 0.33
Former, no. (%) 23 (17.3) 26 (21.3)
Current, no. (%) 69 (51.9) 52 (42.6)
Elevated alcohol use§, no. (%) (n = 248) 31 (24.0) 32 (26.9) 0.6
Low physical activity¶, no. (%) (n = 221) 20 (18.2) 15 (13.5) 0.34
Comorbidities Hypertension‖, no. (%) 69 (51.9) 54 (44.3) 0.22
Systolic blood pressure, mm Hg 134 (22) 130 (25) 0.2
LDL cholesterol, mmol/l 3.2 (1.0) 3.5 (1.2) 0.08
Diabetes**, no. (%) 23 (17.3) 16 (13.1) 0.35
Obesity, no. (%) 26 (19.5) 26 (21.3) 0.73
Depression††, no. (%) (n = 246) 36 (27.7) 27 (23.3) 0.42
Medication before hospitali-
sation
Statins, no. (%) 27 (20.3) 38 (31.2) 0.047
High-dose statins, no. (%) 7 (5.3) 9 (7.4) 0.49
Antihypertensive drugs, no. (%) 68 (51.1) 45 (36.9) 0.022
LDL = low density lipoprotein; MET = metabolic equivalent
Data are given as means (standard deviations) unless otherwise indicated.
* Low household income: CHF 6000 (€ 5120) or less.
† High household income: more than CHF 6000 (€ 5120).
‡ Defined as CHF 300 or 500 (€ 256 or 426.60), compared to CHF 1000, 1500, 2000 or 2500 (€ 853.30, € 1280, € 1706.60 or € 2133.30).
§ Defined as more than 14 units of alcohol per week.
¶ Defined as less than 500 MET-min per week.
‖ Defined as a systolic blood pressure ≥140 mm Hg, a diastolic blood pressure ≥90 mm Hg, or use of blood pressure lowering drugs.
** Based on patients’ self-reporting, use of antidiabetic medication/insulin, or a haemoglobin A1c of ≥6.5%.
†† Defined as a score ≥16 on the 20 items Centre for Epidemiologic Studies Depression Scale (CES-D).
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Figure 1: Association between income and control of cardiovascular risk factors one year after acute coronary syndrome.
with an income above the Swiss median. One year after
hospital discharge for ACS, rates of smoking cessation and
blood pressure control were lower among patients with a
lower income than patients with a higher income, even af-
ter adjusting for other socio-demographic variables such as
education, living status and working status.
Several studies have previously reported an association be-
tween socioeconomic status and cardiovascular outcomes
among patients with pre-existing cardiovascular disease [7,
Table 2: One-year control of cardiovascular risk factors and household income
n Achieved tar-
get (n)
OR (95% CI) p-value R2 Age- and sex-ad-
justed OR
p-value R2 Multivariate-adjust-
ed OR*
p-value R2
Lipid target† 243
Low income 88 1.00 NA 1.00 NA 1.00 NA
High income 96 1.97 (1.08–3.62) 0.02 0.02 1.60 (0.84–3.03) 0.15 0.04 1.72 (0.86–3.45) 0.12 0.05
Blood pressure target‡ 211
Low income 65 1.00 NA 1.00 NA 1.00 NA
High income 81 2.44 (1.33–4.48) 0.004 0.03 2.37 (1.25–4.52) 0.008 0.04 2.19 (1.09–4.41) 0.029 0.06
Stop smoking 126
Low income 22 1.00 NA 1.00 NA 1.00 NA
High income 34 4.15 (1.96–8.80) <0.001 0.08 4.74 (2.13–10.59) <0.001 0.11 3.82 (1.58–9.24) 0.003 0.16
Adherence§ 243
Low income 107 1.00 NA 1 NA 1.00 NA
High income 103 1.31 (0.62–2.74) 0.48 0.003 1.08 (0.49–2.38) 0.86 0.02 1.27 (0.55–2.94) 0.58 0.05
CI = confidence interval; LDL = low density lipoprotein; NA = not available OR = odds ratio; R2 = goodness of fit Low household income: CHF 6000 (€ 5120) or less; high household
income: more than CHF 6000 (€ 5120). * Adjusted for age, sex, education, living status and working status. † LDL below 1.8 mmol/l, 50% decrease or high-dose statin use. ‡
Blood pressure <140/90 mm Hg. § Using drugs according to guidelines, defined as the concomitant use of aspirin, statin and either angiotensin-converting enzyme inhibitors,
angiotensin-receptor blockers or beta-blockers.
Table 3: Quality of care measured one year after discharge, by household income
Low income*
(n = 133)
High income†
(n = 122)
p-value
Visit to a primary care physician, no. (%) (n = 242) 122 (97.6) 115 (98.3) 0.71
Visit to a cardiologist, no. (%) (n = 240) 102 (82.9) 113 (96.6) 0.001
Cardiac rehabilitation, no. (%) (n = 238) 90 (72.6) 91 (79.8) 0.19
Use of hypertensive drugs, no. (%) (n = 243) 123 (97.6) 110 (94.0) 0.16
Use of statins, no. (%) (n = 243) 115 (91.3) 113 (96.6) 0.09
Use of aspirin, no. (%) (n = 243) 119 (94.4) 113 (96.6) 0.42
* Low household income: CHF 6000 (€ 5120) or less † High household income: more than CHF 6000 (€ 5120).
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9, 15]. These studies showed that patients with low socioe-
conomic status face worse cardiovascular outcomes and
have a worse lifestyle compared to patients with a high
socioeconomic status. However, only a few studies have
examined the income of patients in the context of ACS
[1, 3, 8, 9, 15, 16]. In these studies, the outcomes that
were evaluated were mainly the recurrence of cardiovas-
cular events or mortality, but not many studies reported
comprehensive data on the control of cardiovascular risk
factors. A previous study from Canada examined the as-
sociation between income and one-year use of statins and
antihypertensive drugs after ACS [1]. They found that pa-
tients with lower incomes had a lower use of statins and
antihypertensive drugs one year after ACS compared to
those with higher incomes. One study of healthy partici-
pants in the USA showed that among that group both in-
come and education were independently associated with
systolic blood pressure [16]. Consistent with these studies,
we also found a worse one-year control of blood pressure
in the low-income group compared to the high-income
group, even though baseline levels of systolic blood pres-
sure were not different. However, we did not find major
differences in drug adherence between the two income cat-
egories one year after ACS. Therefore, it remains unclear
whether patients in the high-income category better control
their blood pressure through lifestyle changes or through
optimal drug adherence.
We found that one-year smoking cessation was more com-
monly achieved by patients in the high-income category
than those in the low-income category, even after adjust-
ment for socio-demographic variables. Previous studies
performed in the general population have reported a con-
sistent association between income and smoking cessation
rates [17, 18]. However, among patients with ACS, the
specific role of income for smoking cessation has been
studied less. Similar to our results, one previous study
among patients with ACS from the USA found that smok-
ers with higher household incomes had substantially higher
odds of quitting than low-income smokers, but the follow-
up duration was limited to eight months [17]. Among pa-
tients undergoing percutaneous coronary intervention, a
study from Luxembourg found that smoking cessation was
also significantly associated with income, but less than
20% of these patients had ACS [18]. Consistent with these
studies, we also found a lower rate of smoking cessation
in the low-income group than in the high-income group
among ACS patients. Furthermore, we were able to
demonstrate that income remained significantly associated
with smoking cessation rates even after adjustment for ed-
ucation, living status and working status, thus demonstrat-
ing the specific role of income. The reason for this strong
effect of income compared to social status or education re-
mains unclear. It is possible that income better reflects so-
cial status and lifestyle than other parameters in today’s so-
ciety.
Our study has several limitations. Firstly, information on
income was obtained using a self-reported questionnaire.
Although most previous studies have examined outcomes
with self-reported questionnaires rather than with adminis-
trative records, we cannot exclude a misclassification bias
in our study [19, 20]. In fact, one review highlighted the
many possible contributors to inaccurate reporting during
the measurement of income in surveys [20]. However, in
our study we measured household income rather than the
income of individuals in order to take into account the fam-
ily situation and to avoid someone claiming the income of
the main earner as his or her own income. This is a strength
of our approach. Secondly, we had a relatively small sam-
ple of ACS patients with income information available.
Therefore, we could not examine the interactions between
all confounding factors. Still, we were able to adjust our
results for important social variables such as education,
working status and living status. Furthermore, we exam-
ined the impact of income after an ACS in a country with
universal health insurance, in which patients have access to
health care independently of their income.
Conclusions
Among patients with ACS who have mandatory universal
health insurance, the optimal control of cardiovascular risk
factors one year after hospital discharge differed according
to household income. Inequalities were evident for smok-
ing cessation and blood pressure control, but not for the use
of recommended drugs after ACS, or for attaining a lipid
target. Universal health insurance coverage may limit the
impact of income inequality regarding drug use after ACS,
but not regarding changes in lifestyle and behaviour.
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Supplementary data
Table S1: Income categories based on the original self-reported ques-
tionnaire (n = 255).
Number Percentage (%)
<CHF 3000 (<€ 2560) 29 11.4
CHF 3000 (€ 2560) 7 2.7
CHF 3000 to 4500 (€ 2560
to € 3840)
37 14.5
CHF 4500 (€ 3840) 8 3.1
CHF 4500 to 6000 (€ 3840
to € 5120)
52 20.4
CHF 6000 (€ 5120) 12 4.7
CHF 6000 to 9000 (€ 5120
to € 7680)
59 23.1
CHF 9000 (€ 7680) 6 2.4
>CHF 9000 (>€ 7680) 45 17.6
Table S2: One-year smoking cessation and household income, according to different scenarios for missing information.
n Achieved target
(n)
OR (95% CI) p-value R2 Age- and sex-ad-
justed OR
p-value R2 Multivariate-adjust-
ed OR*
p-value R2
Stop smoking† 126
Low income 22 1.00 NA 1.00 NA 1.00 NA
High income 34 4.15 (1.96–8.80) <0.001 0.08 4.74 (2.13–10.59) <0.001 0.11 3.82 (1.58–9.24) 0.003 0.16
Stop smoking‡ 126
Low income 26 1.00 NA 1.00 NA 1.00 NA
High income 37 4.18 (1.96–8.91) <0.001 0.08 4.59 (2.07–10.18) <0.001 0.10 4.15 (1.71–10.07) 0.002 0.15
CI = confidence interval; NA = not available OR = odds ratio; R2 = goodness of fit
Low household income: CHF 6000 (€ 5120) or less; high household income: more than CHF 6000 (€ 5120).
* Adjusted for age, sex, education, living status and working status.
† considering the seven smokers with missing information for smoking cessation at one year as current smokers (worst case scenario).
‡ considering the seven smokers with missing information for smoking cessation at one year as non-smokers (best case scenario).
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